Aspen approved for secondary listing on A2X


The complementary A2X listing offers investors trading benefits, says Aspen Group CEO Stephen Saad.

Aspen Pharmacare Holdings Ltd has been approved for a secondary listing on A2X Markets and will list on 1 April 2019. 

Aspen Group CEO Stephen Saad (pictured) said: 

“We continually strive to identify ways to increase value for our shareholders and the complementary A2X listing offers investors trading benefits while simultaneously providing the prospect of increasing our shareholder base. We will retain our primary listing on the Johannesburg Stock Exchange and our issued share capital will be unaffected by the secondary listing.”

The leading specialty and branded multinational pharmaceutical company will retain its primary listing on the JSE and its issued share capital will be unaffected by the secondary listing. 

A2X CEO Kevin Brady also commented: 

“A2X is thrilled to have South Africa’s largest pharmaceutical company on board. No doubt that Aspen will reap the benefits of a secondary listing, including the opportunity to attract potential new investors through A2X’s lower-cost trading structure and broadening their shareholder base." 

Related articles

CFO Zaf Mahomed is casting a new net at Oceana

CFO Zaf Mahomed reveals why balance sheet management and cash flow are the only tools you need to make your organisation’s profits grow. He uses his recent experience at Oceana Group as an example.

CFO Jan Hofmeyr shares his blueprint for technological transformation

Passionate about the opportunity technology can bring, 2023 Finance & Technology Award winner Jan Hofmeyr has been breaking the CFO mould at OUTsurance by driving the transformation of its finance department so it remains relevant in an increasingly digital future. He reveals how this change has affected the entire business.

CFO Raisibe Morathi explores the nexus of connectivity

CFO Raisibe Morathi, CFO of the Year 2023 and winner of the Strategy Execution Award as well as the High-Performance Team Award, reveals how she balances technology and people to foster the ultimate digital, financial and cultural inclusion, as Vodacom Group transforms to become part of the digital revolution.

Bringing Joy to Discovery Health Medical Scheme as CFO

Discovery Health Medical Scheme CFO Joy Malete says that her rapid career progression has been the result of “divine orchestration”. Just 34, her success is rooted in curiosity, talent, and a true passion for what she does.